1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Blood Platelet Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, ZY | 1 |
| Tiffany, ML | 1 |
| Keenan, JP; Machin, SJ; McVerry, BA | 1 |
| Dangelmaier, C; Hassell, B; Holmsen, H; Rao, AK; Smith, JB; Willis, J | 1 |
| Gogstad, G; Solum, NO; Stormorken, H | 1 |
| Champeix, P; Favier, R; Hurtaud, MF; Kaplan, C; Lecompte, T; Morel, MC; Potevin, F; Samama, M; Schlegel, N | 1 |
| Yamazaki, H | 1 |
| Kanaji, K; Okuma, M; Sensaki, S; Sugiyama, T; Uchino, H; Ushikubi, F | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Blood Platelet Disorders
| Article | Year |
|---|---|
Technical considerations for platelet aggregation and related problems.
Topics: Aging; Anesthetics; Anticoagulants; Blood Platelet Disorders; Blood Platelets; Catheterization; Diet; Humans; Indicators and Reagents; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Smoking; Stress, Physiological; Temperature; Time Factors | 1983 |
[Recent medical topics on platelets in hemorrhagic and thrombotic diseases].
Topics: Blood Platelet Disorders; Blood Platelets; Hemorrhagic Disorders; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1986 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Blood Platelet Disorders
| Article | Year |
|---|---|
[Advances in the physiopathology of platelets].
Topics: Blood Platelet Disorders; Blood Platelets; Calcium; Cyclic AMP; Humans; Platelet Activating Factor; Receptors, Cell Surface | 1984 |
Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.
Topics: Arachidonic Acids; Bleeding Time; Blood Platelet Disorders; Calcimycin; Calcium; Female; Humans; Middle Aged; Nucleotides; Platelet Activating Factor; Platelet Aggregation; Thromboxane A2 | 1983 |
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects.
Topics: Adenosine; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelet Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thrombin; Thromboxanes | 1984 |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF).
Topics: Adenosine Diphosphate; Adolescent; Blood Coagulation Tests; Blood Platelet Disorders; Epinephrine; Hemorrhagic Disorders; Humans; Male; Platelet Activating Factor; Platelet Aggregation | 1983 |
Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
Topics: Adenosine Diphosphate; Aequorin; Blood Platelet Disorders; Blood Platelets; Calcimycin; Calcium; Collagen; Humans; In Vitro Techniques; Luminescent Proteins; Platelet Activating Factor; Platelet Aggregation; Tetradecanoylphorbol Acetate; Thrombasthenia; Thrombin | 1990 |
A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia.
Topics: Autoimmune Diseases; Blood Coagulation Factors; Blood Platelet Disorders; Collagen; Female; Humans; Immunoglobulin G; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Purpura, Thrombocytopenic; Thrombocytopenia; Thromboxane B2 | 1987 |